Methinks AI is the first company to receive CE mark for AI-based LVO assessment support on non-contrast CT. This achievement contributes to the evolution of early stroke care globally.

The medtech giant plans to integrate Methinks AI’s apps with its portfolio of ischemic stroke treatment hardware, including blood clot aspiration systems and stent-based retrievers.

Dr. Santiago Ortega-Gutiérrez at the 2024 SVIN, San Diego, California. Methinks AI powers Done Symple trial to expand stroke treatment window to 24-72 hours using only non-contrast CT for patient ...

Methinks Stroke Suite, AI-based software, is a radiological computer aided triage and notification system which uses AI algorithms to identify suspected LVO on non-contrast computed tomography ...

Methinks Software SL (dba Methinks.AI), a digital health company, is working on the U.S. FDA submission for its artificial intelligence (AI)-based stroke triage software, which will aid in the ...

MOUNTAIN VIEW, Calif., Sept. 5, 2019 /PRNewswire-PRWeb/ -- methinks, the creators of a global marketplace for customer insights powered by its video-based research platform, today announces ...

BARCELONA, Spain, Feb. 21, 2023 /PRNewswire/ -- Methinks, a digital health Company that specializes in early detection and management of Acute Stroke (AS), using artificial intelligence (AI ...